Evidence map›Paper›PMID 32796247›Full record

ArticleClinical nuclear medicine2020

One-by-One Comparison of Lymph Nodes Between 18F-FDG Uptake and Pathological Diagnosis in Esophageal Cancer.

Shuntaro Yoshimura, Miwako Takahashi, Susumu Aikou, Yasuhiro Okumura, Keiichi Jinbo, Haruna Onoyama, Masayuki Urabe, Koichiro Kawasaki, Koichi Yagi, Masato Nishida and 9 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Clinical nuclear medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Updated evidence on the accuracy ofQuantitative imaging in medicine and surgery · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Comparison of [Frontiers in oncology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Shuntaro YoshimuraFrom the Department of Gastrointestinal Surgery, Graduate School of Medicine.
Miwako TakahashiDepartment of Nuclear Medicine, The University of Tokyo.
Susumu AikouFrom the Department of Gastrointestinal Surgery, Graduate School of Medicine.
Yasuhiro OkumuraFrom the Department of Gastrointestinal Surgery, Graduate School of Medicine.
Keiichi JinboFrom the Department of Gastrointestinal Surgery, Graduate School of Medicine.
Haruna OnoyamaFrom the Department of Gastrointestinal Surgery, Graduate School of Medicine.
Masayuki UrabeFrom the Department of Gastrointestinal Surgery, Graduate School of Medicine.
Koichiro KawasakiFrom the Department of Gastrointestinal Surgery, Graduate School of Medicine.
Koichi YagiFrom the Department of Gastrointestinal Surgery, Graduate School of Medicine.
Masato NishidaFrom the Department of Gastrointestinal Surgery, Graduate School of Medicine.
Kazuhiko MoriDepartment of Gastrointestinal Surgery, Mitsui Memorial Hospital.
Hiroharu YamashitaFrom the Department of Gastrointestinal Surgery, Graduate School of Medicine.
Sachiyo NomuraFrom the Department of Gastrointestinal Surgery, Graduate School of Medicine.
Keitaro KoyamaDepartment of Nuclear Medicine, The University of Tokyo.
Toshimitsu MomoseDepartment of Nuclear Medicine, The University of Tokyo.
Hiroyuki AbeDepartment of Pathology, The University of Tokyo, Tokyo, Japan.
Tetsuo UshikuDepartment of Pathology, The University of Tokyo, Tokyo, Japan.
Masashi FukayamaDepartment of Pathology, The University of Tokyo, Tokyo, Japan.
Yasuyuki SetoFrom the Department of Gastrointestinal Surgery, Graduate School of Medicine.
The University of Tokyo · JPMitsui Memorial Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeEsophagectomy with extended lymph node (LN) dissection is a standard treatment for resectable esophageal cancer to prevent recurrence, but severe, potentially life-threatening postoperative complications are still important issues. Accurate diagnosis of LN metastases would enable the decision to dissect or leave the LNs in regions with high risk of complications. Advancements in intraoperative gamma probe and radioactivity detectors have made intraoperative navigation surgery possible using a radiotracer as a marker. F-FDG is one such candidate markers, and the diagnostic power of FDG through counting the radioactivity close to each LN should be elucidated. MATERIALS AND

methodsIn 20 patients, 1073 LNs including 38 metastatic LNs were prospectively investigated. Preoperative FDG PET was performed on the same day before esophagectomy and visually surveyed in each LN station to identify abnormal uptake. The FDG radioactivity of each individual dissected LN was measured by a well-type counter, and the pathological diagnosis was compared with LN radioactivity on a one-by-one basis and with the preoperative FDG PET findings for each LN station.

resultsLymph node station-based analysis showed a sensitivity and specificity of 28.6% and 96.7%, respectively. One-by-one LN-based analysis using a cutoff value obtained from the receiver operating characteristic curve showed a sensitivity and specificity of 94.7% and 78.7%, respectively, demonstrating higher accuracy compared with the use of LN weight or the shortest diameter.

conclusionsThe FDG uptake by each LN is a potentially useful marker for navigation surgery in esophageal cancer and has higher accuracy than LN weight or diameter.

Indexed as

AgedEsophageal NeoplasmsFemaleFluorodeoxyglucose F18HumansLymphatic MetastasisLymph NodesMaleMiddle AgedPositron Emission Tomography Computed TomographySensitivity and SpecificityFluorodeoxyglucose F18

Identifiers

PMID32796247
PMCPMC7469872
OpenAlexW3060654736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.